
NDEV’s Q3 2026 Financials, Regulatory Strategy, and Dual-Platform PBM Model
Q3 2026 Earnings and Capital Allocation
Novus Acquisition & Development Corp. (OTC: NDEV), operating as Novus Cannabis MedPlan, recently filed its Q3 2026 interim financial report, extending a sustained trajectory of top-line expansion to 14 consecutive quarters. The company reported a 7.78% year-over-year increase in gross revenue, driven by disciplined premium collection and policyholder retention. Asset expansion tracked positively, with year-to-date total assets up 2.34% and stockholders’ equity up 2.26%.
In a sector characterized by distressed balance sheets, NDEV’s capital structure warrants specific institutional focus because it lacks toxic debt. The firm maintains an unleveraged position with a 9.74% debt-to-equity ratio and holds zero outstanding convertible notes or debentures. This structure effectively insulates the equity base from the highly dilutive debt-to-equity conversions currently restructuring the balance sheets of traditional plant-touching Multi-State Operators (MSOs). Furthermore, corporate governance protocols are rigidly enforced to preserve market integrity: management reports 0% insider share liquidation over the trailing 36-month period and enforces a strict 15% Vendor Share Leak-Out Provision. This programmatic cap on the liquidation of restricted stock issued for third-party services mitigates the risk of equity saturation, helping retain fundamental value for retail and institutional shareholders alike.
Strategic Hedging Amid Regulatory and Banking Gridlock
The broader cannabis ecosystem remains bottlenecked by federal illegality, severely restricting access to traditional commercial banking and sidelining major institutional capital due to strict compliance mandates. While plant-touching operators burn significant cash reserves lobbying for the passage of the SAFE Banking Act, NDEV utilizes an asset-light, non-plant-touching health insurance model as a structural hedge. By deriving revenue exclusively from insurance premiums rather than the direct cultivation or sale of cannabis, the company bypasses federal banking restrictions and punitive tax classifications.
This positioning allows the firm to preserve and reinvest capital and accumulate market share while patiently waiting out the government’s delayed regulatory rollout. For major institutional funds unable to allocate capital to federally illegal operations, NDEV represents a compliant, legally insulated vehicle to gain exposure to the expanding cannabis consumer base. Similarly, retail investors benefit from a model that does not rely on immediate legislative catalysts for survival. By operating outside the capital-intensive debt traps of traditional cultivation models, Novus utilizes its status as a licensed health insurance carrier to build a sustainable, self-funded operational footprint, effectively hedged against ongoing legislative gridlock.
Dual-Platform Architecture and PBM Agility
Operationally, NDEV mitigates institutional integration risk through a proprietary dual-platform compliance firewall. This infrastructure structurally separates traditional healthcare benefits from alternative medicine. Platform A is dedicated exclusively to federally compliant prescription drug (Rx) plans, while Platform B functions as a fully segregated ecosystem for Cannabis, CBD, and THC policies. This strict segregation ensures that traditional network providers and healthcare partners are insulated from cannabis commerce, maintaining absolute FDA and DEA compliance under current law.
Underpinning this dual-platform architecture is NDEV’s capability to operate as its own internal Pharmacy Benefit Manager (PBM) for alternative medicine. By controlling administrative data routing, provider network integration, and the underlying Premium-Aligned Provider Remittance (PAPR) economics (a/k/a Reimbursement), Novus retains comprehensive control over its plan design. This PBM agility provides a critical operational moat. As federal rules and regulations—such as a DEA Schedule III reclassification—are finalized, NDEV is positioned to pivot immediately. Internal PBM mechanics allow management to swiftly modify policy structures, merge segregated platforms, and execute unified claims processing, ensuring immediate operational readiness as modernized federal frameworks are implemented.
For comprehensive financial disclosures, GAAP compliance details, and further corporate strategy analysis, visit www.getnovusnow.com/investor-relations.


